NECTIN THERAPEUTICS
Nectin Therapeutics is developing novel monoclonal antibodies directed towards members of the Nectin family of receptors and ligands that have major roles in the immune checkpoint mechanisms relevant for cancer immune therapy. These novel antibodies are developed for the treatment of solid and hematological malignancies.
NECTIN THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.nectintx.com
Total Employee:
1+
Status:
Active
Contact:
+972 5 4424 7524
Email Addresses:
[email protected]
Total Funding:
11.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Baseimmune
Baseimmune is a biotech startup founded to create the next generation of vaccines.
CytoLynx Therapeutics
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Neuroglee Therapeutics
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
TransThera Biosciences
TransThera Biosciences is a biotech company that specializes in the treatment of oncology, cardiovascular, and inflammatory diseases.
Vazyme Biotech
Vazyme Biotech is devoted to the development and production of enzymes and antibodies.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cancer Focus Fund
Cancer Focus Fund investment in Venture Round - Nectin Therapeutics
aMoon Fund
aMoon Fund investment in Venture Round - Nectin Therapeutics
Integra Holdings
Integra Holdings investment in Seed Round - Nectin Therapeutics
Official Site Inspections
http://www.nectintx.com Semrush global rank: 4.82 M Semrush visits lastest month: 1.88 K
- Host name: 172.67.199.123
- IP address: 172.67.199.123
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nectin Therapeutics"
Homepage - Nectintx
NectinTX is a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy agents.See details»
Pini Tsukerman (Ph.D) - Nectintx
Pini’s scientific achievements laid the foundation for the first Nectin Therapeutics program, and following the establishment of the company in 2017, he was named Chief Scientific Officer. Pini is mentoring the team and leading all research …See details»
About Us - Nectintx
Nectin Therapeutics is a venture-backed, privately held company, funded by aMoon Fund, Peregrine Ventures, IBF, Integra Holdings, Cancer Focus Fund, and Myeloma Investment Fund. We are a biotech company devoted to …See details»
Nectin Therapeutics - Crunchbase Company Profile
Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies. View contacts for Nectin Therapeutics to access new leads and connect with decision-makers.See details»
The Centre for Proteomics: pioneering research and …
Aug 7, 2023 · In 2017, the Centre for Proteomics co-founded Nectin Therapeutics Ltd. (NectinTx), a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy …See details»
Nectin Therapeutics - LinkedIn
At Nectin, we are dedicated to the development of novel therapeutic options for cancer patients. We are developing a diverse pipeline of targeted antibodies based on the nectin pathways. These...See details»
Nectin Therapeutics - Next-generation Immunotherapy Agents
Dec 1, 2022 · Nectin Therapeutics is a biotechnology company devoted to transforming the lives of cancer patients by the development of next-generation immune-oncology (IO) therapies. …See details»
Nectin Therapeutics – Integra Holdings
Integra Holdings, aMoon, Peregrine and Marius Nacht. www.nectintx.com. At a glanceA biotechnology company devoted to transforming the lives of cancer patients by pioneering the …See details»
Nectin Therapeutics Licenses Novel Antibodies to Immunome
Jul 25, 2024 · Nectin Therapeutics is a clinical stage biotechnology company devoted to transforming the lives of cancer patients by leveraging unique insights into Nectin pathways to …See details»
Our Team - Nectintx
We welcome discussions around the scientific basis of our approach, ideas and discussions around collaboration.See details»
Nectin Therapeutics Adds Combination Therapy Arm and Expands …
Dec 18, 2023 · NTX1088 is Nectin's first-in-class lead candidate – a highly potent monoclonal antibody directed against PVR (CD155), a transmembrane protein expressed on cancer cells …See details»
Nectin Therapeutics Company Profile 2024: Valuation, Funding ...
Operator of a biotechnology company intended to treat solid and hematological malignancies. The company develops antibodies that overcome inhibitory pathways deployed by the tumors and …See details»
aMoon Fund Leads Investment Round in Nectin Therapeutics with …
Tel Aviv, Israel — July 14, 2020 — aMoon Velocity, the early-stage fund of Israel’s largest HealthTech and life sciences venture fund aMoon, today announced an investment round with …See details»
Nectin Therapeutics Announces Extended Series A Financing to
Nov 30, 2022 · Nectin Therapeutics Ltd announced today dosing of the first patient in its Phase 1 clinical trial of NTX1088, Nectin’s first-in-class PVR (CD155) blocker, in cancer patients with …See details»
Media - Nectintx
Dec 26, 2023 · We welcome discussions around the scientific basis of our approach, ideas and discussions around collaboration.See details»
Nectin Therapeutics Announces $5.4 Million Investment from …
JERUSALEM and HOUSTON, March 7, 2022 /PRNewswire/ -- Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies that address resistance …See details»
Nectin - VentureRadar
Website: http://www.nectintx.com/ Develops next-generation immune oncology therapies, focusing on monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat …See details»
Nectin Therapeutics - Overview, News & Similar companies
View Nectin Therapeutics (www.nectintx.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Fabian Tenenbaum - Nectintx
Fabian joined Nectin Therapeutics in October 2021 as Chief Executive Officer and member of our Board of Directors. Prior to that, Fabian served as the CEO of Bellerophon Therapeutics, CFO …See details»
Nectin Therapeutics Announces Extended Series A Financing to …
Nov 30, 2022 · JERUSALEM and FORT LEE, NJ, Nov. 30, 2022 /PRNewswire/ -- Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted …See details»